Bartlett & Co Wealth Management’s Bio-Techne TECH Stock Holding History

Bartlett & Co Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.97K	Sell	42 -7	-14%	-$378	﹤0.01%	1132
2026 Q1	$2.68K	Hold	49	–	–	﹤0.01%	1093
2025 Q4	$2.88K	Hold	49	–	–	﹤0.01%	1093
2025 Q3	$2.73K	Buy	+49	New	+$2.63K	﹤0.01%	1073
2025 Q2	–	Sell	-2	Closed	-$117	–	1326
2025 Q1	$117	Buy	+2	New	+$136	﹤0.01%	1200
2024 Q4	–	Sell	-172	Closed	-$13.7K	–	1152
2024 Q3	$13.7K	Hold	172	–	–	﹤0.01%	878
2024 Q2	$12.3K	Hold	172	–	–	﹤0.01%	897
2024 Q1	$12.1K	Hold	172	–	–	﹤0.01%	890
2023 Q4	$13.5K	Buy	+172	New	+$11.3K	﹤0.01%	955
2021 Q1	–	Sell	-44	Closed	-$3.49K	–	1190
2020 Q4	$3.49K	Buy	+44	New	+$3.19K	﹤0.01%	838

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bartlett & Co Wealth Management's TECH Position: Q2 2026 in Review

Bartlett & Co Wealth Management reduced its Bio-Techne (TECH) stake by 14% in Q2 2026, selling an estimated $378 and leaving 42 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Bartlett & Co Wealth Management first reported a position in TECH in Q4 2020 and has held it in 10 quarters since. The position peaked at $13.7K in Q3 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Bartlett & Co Wealth Management held 42 shares of Bio-Techne worth $2.97K as of Q2 2026.
Bartlett & Co Wealth Management sold 7 Bio-Techne shares in Q2 2026, an estimated $378.
Bio-Techne made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1132 holding.
Bartlett & Co Wealth Management first reported a position in Bio-Techne in Q4 2020 and has held it in 10 quarters since.
Bartlett & Co Wealth Management's Bio-Techne position peaked at $13.7K in Q3 2024.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.